Pharmaceuticals

Global Alzheimer’s Disease Treatment Market Size, Forecasts, And Opportunities

November 23, 2021 by The Business Research Company

Learn about the global Alzheimer’s disease treatment market through The Business Research Company, which provides information on Alzheimer’s disease treatment market size, Alzheimer’s disease treatment market drivers and restraints, Alzheimer’s disease treatment market players, the COVID-19 impact on the Alzheimer’s disease treatment market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global Alzheimer’s disease treatment market is expected to grow from $3.43 billion in 2020 to $3.76 billion in 2021 at a compound annual growth rate (CAGR) of 9.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global Alzheimer’s disease treatment market is expected to reach $5.91 billion in 2025 at a CAGR of 12%.

The increasing cases of Alzheimer’s is expected to drive innovation in Alzheimer’s disease treatment, thus driving the market during the forecast period.

Request A Sample For The Global Alzheimer’s Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3409&type=smph

The global Alzheimer’s disease treatment market consists of sales of drugs used to treat Alzheimer’s disease. Alzheimer’s disease is a progressive neurological disorder causing degeneration of brain cells, resulting in dementia (a condition that causes a decline in thinking, behavioural and social skills). The progression of this disease causes severe memory impairment and the person may lose the ability to carry out everyday tasks.

Global Alzheimer’s disease treatment market segments include:

By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins

By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists

By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Increasing R&D investments and collaborations due to the emerging technologies for the treatment is a key trend in Alzheimer’s disease (AD) treatment market. The Alzheimer’s Association is assisting with funds to researchers in search of innovative therapeutic approaches and seeks more government funding for Alzheimer’s studies. Technologies such as ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and anti-amyloid inhibitors are emerging in the AD market.

TBRC’s Alzheimer’s disease treatment market report covers:

Major Market Players: Allergan, Eisai Co. Ltd., Novartis AG, Pfizer Inc., Merz Pharma, H. Lundbeck A/S Biogen, AstraZeneca, and F. Hoffmann-La Roche Ltd.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Alzheimer’s Disease Treatment Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides Alzheimer’s disease treatment market overviews, analyzes and forecasts market size, share, Alzheimer’s disease treatment market players, Alzheimer’s disease treatment market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s Alzheimer’s disease treatment market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Neurophysiology Devices And Equipment Global Market Report 2021

Neurostimulation Devices Global Market Report 2021

Interventional Neurology Devices And Equipment Global Market Report 2021

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model